The objectives of this project are: 1) to comprehensively characterize a large national cohort of patients with suspected myocarditis, their clinical phenotype, care management, blood and imaging biomarkers, epidemiological, environmental and genetic data; 2) to retrospectively validate the accuracy of the new hsa-RNA-Chr8:96 biomarker for the diagnosis of myocarditis compared to conventional diagnosis; 3) to identify acquired and inherited mutations, and their interaction with the environment, which explain the susceptibility to myocarditis, its severity and response to treatment; 4) to study the lower incidence in women and the influence of age, considering socio-health and genetic factors.
Acute chest pain: pericardial or pseudo-ischemic.
Dyspnea on exertion or at rest for up to 3 months.
Dyspnea on exertion or at rest for 3 months - 1 year.
Unexplained palpitations / arrhythmias, sudden death recovered.
None
All patients with clinical suspicion of myocarditis or inflammatory cardiomyopathy will be included, based on the presence of compatible clinical findings.
Cohort
Prospective
characterization of a large national cohort of patients with suspected myocarditis or inflammatory cardiomyopathy.
Other interventioncharacterization of a large national cohort of patients with suspected myocarditis or inflammatory cardiomyopathy.
characterization of a large national cohort of patients with suspected myocarditis or inflammatory cardiomyopathy.
Subjects will be recruited during an emergency room visit or within their usual clinical practice among those patients who meet the criteria for participation in the study.
Click on the lead sponsor to view all of their trials.
